Skip to main content
Avicanna Inc. (TSX:AVCN)
Canada flag Canada · Delayed Price · Currency is CAD
0.150
+0.005 (3.45%)
Apr 28, 2026, 3:25 PM EST

Avicanna Revenue

In the year 2025, Avicanna had annual revenue of 25.48M CAD with 0.08% growth. Avicanna had revenue of 6.60M in the quarter ending December 31, 2025, a decrease of -0.25%.

Revenue
25.48M
Revenue Growth
+0.08%
P/S Ratio
0.72
Revenue / Employee
227.49K
Employees
112
Market Cap
18.24M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202525.48M19.48K0.08%
Dec 31, 202425.46M8.67M51.62%
Dec 31, 202316.79M12.74M314.82%
Dec 31, 20224.05M778.98K23.83%
Dec 31, 20213.27M1.70M108.20%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Voyageur Pharmaceuticals 30.96K
Ayr Wellness 650.97M
Red Light Holland 4.17M
Red White & Bloom Brands 70.97M
1CM Inc. 75.01M
Greenway Greenhouse Cannabis 9.13M
Crescita Therapeutics 21.12M
MediPharm Labs 45.12M
Revenue Rankings

Avicanna News

More News